Clinical trial
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
NCT02918370 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- June 30, 2023
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol abuse, alcoholism, bipolar disorder